I know there is a lot of interest in radiopharmaceuticals. This will be a Phase 1 (dose finding) trial, meaning everyone gets the radiopharmaceutical. In the US, MSK in NYC is the only site so far.
Newest radiopharmaceutical: Th-227-PS... - Advanced Prostate...
Newest radiopharmaceutical: Th-227-PSMA-antibody
Written by
Tall_Allen
To view profiles and participate in discussions please or .
1 Reply
•
It's nice seeing all this radiopharmaceutical activity.
Not what you're looking for?
You may also like...
Test of a new Lu-177-PSMA-based radiopharmaceutical at UCSF
I know many patients are interested in trying a Lu-177-PSMA-based radiopharmaceutical without being...
Article: 'Major Milestone' in mCRPC: Radiopharmaceutical Boosts Survival
A novel radiopharmaceutical has been shown to boost survival when added to standard treatment for...
New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer: Tagawa did it again?
That guy is a machine! ARX517 and then this? wow...but what will we do with all the Lutetium??...
New Clinical Trial. Clinical trial evaluates radiopharmaceutical as therapy for biochemically recurrent prostate cancer
Radium 223 for micrometastasis treatment in patients with BCR.|...
Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
In this fairly small real world study the FRAMCAP database was used to compare cabazitaxel versus...